THÔNG TIN TÀI LIỆU
320 Duboc D, Meune C, Lerebours G, et al Effect of perindopril on the onset and progression of left ventricular dysfunction in duchenne muscular dystrophy J Am Coll Cardiol 2005;45(6):855– 857 321 Silva MC, Meira ZMA, Gurgel Giannetti J, et al Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy J Am Coll Cardiol 2007;49:1874– 1879 322 Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) Lancet 1999;353(9169):2001– 2007 323 Packer M, Fowler MB, Roecker EB, et al Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 2002;106(17):2194–2199 324 Rusconi P, Gomez-Marin O, Rossique-Gonzalez M, et al Carvedilol in children with cardiomyopathy: 3-year experience at a single institution J Heart Lung Transplant 2004;23(7):832–838 325 Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier AK Beta-blockers for congestive heart failure in children Cochrane Database Syst Rev 2016;(1) [CD007037] 326 Shaddy RE, Boucek MM, Hsu DT, et al Carvedilol for children and adolescents with heart failure: a randomized controlled trial JAMA 2007;298(10):1171–1179 327 Reddy S, Fung A, Manlhiot C, et al Adrenergic receptor genotype influences heart failure severity and beta-blocker response in children with dilated cardiomyopathy Pediatr Res 2015;77(2):363–369 328 Medina E, Sucharov CC, Nelson P, Miyamoto SD, Stauffer BL Molecular changes in children with heart failure undergoing left ventricular assist device therapy J Pediatr 2017;182:184– 189 e181 329 Albers S, Meibohm B, Mir TS, Laer S Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure Br J Clin Pharmacol 2008;65(4):511–522 330 Homma S, Thompson JL, Pullicino PM, et al Warfarin and aspirin in patients with heart failure and sinus rhythm N Engl J Med 2012;366(20):1859–1869 331 Homma S, Thompson JL, Qian M, et al Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: warfarin versus aspirin in reduced cardiac ejection fraction trial substudy Circ Heart Fail 2015;8(3):504–509 332 Ziff OJ, Lane DA, Samra M, et al Safety and efficacy of digoxin: systematic review and metaanalysis of observational and controlled trial data BMJ 2015;351:h4451 333 Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 1997;336(8):525–533 334 Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 2003;289(7):871–878 335 Ahmed A, Rich MW, Love TE, et al Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur Heart J 2006;27(2):178– 186 336 Cleland JG, Daubert JC, Erdmann E, et al The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 2005;352(15):1539–1549 337 Abraham WT, Fisher WG, Smith AL, et al
Ngày đăng: 22/10/2022, 12:55
Xem thêm: